Isotretinoin treatment alters steroid metabolism in women with acne

Br J Dermatol. 1991 Apr;124(4):361-4. doi: 10.1111/j.1365-2133.1991.tb00598.x.

Abstract

The effect of isotretinoin (Roaccutane) on serum steroids and urinary steroid metabolites was investigated in seven female patients receiving the drug for treatment of severe acne over a 16-week period. Serum concentrations of dehydroepiandrosterone sulphate (DHAS), androstenedione (A2), and free androgen index (FAI) were not significantly altered. There was a significant fall in testosterone during treatment and a significant reduction in the 24 h urinary excretion of androsterone, tetrahydrocortisone (THE) and tetrahydrocortisol (THF) from week 8 onwards and for aetiocholanolone and allo-THF from week 12 (P less than 0.05). Although pretreatment levels of urinary steroid metabolites were not abnormal, the ratios of the 5 alpha/5 beta metabolites (androsterone:aetiocholanolone and allo-THF:THF) were at the upper limit of the reference range and were lowered after treatment, suggesting that 5 alpha-reductase activity is sensitive to isotretinoin.

MeSH terms

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / metabolism
  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / metabolism
  • Adolescent
  • Adult
  • Androgens / metabolism*
  • Androsterone / urine
  • Etiocholanolone / urine
  • Female
  • Humans
  • Isotretinoin / therapeutic use*
  • Testosterone / blood
  • Tetrahydrocortisol / blood
  • Tetrahydrocortisone / blood

Substances

  • Androgens
  • Testosterone
  • Tetrahydrocortisone
  • Tetrahydrocortisol
  • Etiocholanolone
  • Androsterone
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
  • Isotretinoin